Document:

Amended Employment Agreement  for William Montalto dated 9 August 2004

 Exhibit 10.16 
 AMENDED AND RESTATED EMPLOYMENT AGREEMENT 
 THIS
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”), dated as of August 9, 2004 (the “Execution Date”), is made between STERLING JEWELERS INC., a Delaware corporation (the “Company”), and WILLIAM MONTALTO (the
“Executive”). 
 WHEREAS, the Company is engaged in the business of operating a chain of retail jewelry stores in the
United States (the “Business”); and 
 WHEREAS, the Company and the Executive entered into an Employment Agreement,
dated as of May 10, 1996 and as amended, to the date hereof (the “Original Agreement”); and 
 WHEREAS, the
parties hereby desire to make certain additional amendments to the Original Agreement and, in connection therewith, to amend and restate the Original Agreement; 
 NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and obligations hereinafter set forth, the parties hereto, intending to be legally bound, hereby agree as follows: 

1. Employment and Term. 
 (a) The Company hereby employs the Executive, and the Executive hereby accepts employment by the Company, in the capacities and on the terms and subject to the conditions set forth herein from the
Execution Date until the date this Agreement is terminated by the Company or by the Executive pursuant to the terms of this Agreement (the “Term of Employment”). 

 (b) The Company may terminate this Agreement at any time by notifying the Executive in
writing. In the event the Company terminates this Agreement pursuant to this Section 1(b), the Company shall be obligated to (i) pay the Executive his Base Salary (as defined in Section 3 below) in effect at the effective date of
termination prorated to such date of termination, (ii) pay the Executive for any Annual Bonus (as defined in Section 3 below) ( which amount shall be paid within 30 days following the preliminary announcement by Signet Group plc
(“Signet”) of its results for the related fiscal year) and /or Long Term Bonus (as defined below in Section 3 below) (which amount shall be paid in accordance with the long term incentive plan for executive officers then in effect, as
approved by the Signet Remuneration Committee) earned by Executive for a completed fiscal year (or, in the case of the Long Term Bonus, a completed three-year fiscal period) prior to the effective date of such termination but which remain unpaid as
of the date of termination, (iii) pay the Executive the pro-rata portion of the Annual Bonus for which he was then eligible as of the date of termination for the then current fiscal year (which amount shall be paid within 30 days following the
preliminary announcement by Signet of its results for such fiscal year), (iv) pay the Executive for any vacation days for the current year earned but not used by the Executive and (v) continue to pay to the Executive his Base Salary in
effect on the last date of Executive’s employment for twelve (12) months following such last date of employment, in accordance with the Company’s standard payroll practices for executive officers. The Executive shall continue to have
the obligations provided for in Sections 6 and 7 hereof. 
 (c) The Term of Employment may also be terminated by the Executive
at any time upon three hundred sixty (360) days’ prior written notice to the Company. 
  

 2 

 Upon such termination, the Company shall have no further obligations hereunder except to
(i) pay the Executive his Base Salary in effect at the effective date of such termination prorated to such date of termination, (ii) pay the Executive for any Annual Bonus (as defined in Section 3 below) (which amount shall be paid within
30 days following the preliminary announcement by Signet Group plc (“Signet”) of its results for the related fiscal year) and/or Long Term Bonus (as defined below in Section 3 below) (which amount shall be paid in accordance with the
long term incentive plan for executive officers then in effect, as approved by the Signet Remuneration Committee) earned by the Executive for a completed fiscal year (or, in the case of the Long Term Bonus, a completed three-year fiscal period)
prior to the effective date of such termination but which remain unpaid as of the date of termination, and (iii) pay the Executive for any vacation days for the current year earned but not used by the Executive. The Executive shall continue to
have the obligations provided in Sections 6 and 7 hereof. 
 2. Duties. During the Term of Employment, the Executive
shall serve as Executive Vice President and Chief Administrative Officer of the Company. The Executive shall report to the Chief Executive Officer of the Company. The Executive shall serve the Company faithfully and to the best of his ability in
such capacities, as determined by the Chief Executive Officer of the Company, devoting substantially all of his business time, attention, knowledge, energy and skills to such employment. In addition, if elected, the Executive shall also serve during
any part of the Term of Employment as any other officer or a director of the Company or any subsidiary corporation or parent corporation of the Company, without any compensation therefor other than as specified in this Agreement. 
  

 3 

 3. Compensation and Benefits. As full and complete compensation to the Executive for
his execution and delivery of this Agreement and performance of the services required hereunder, the Company shall pay, grant or provide to the Executive, and the Executive agrees to accept: 
 (a) (i) a base salary, payable in accordance with the Company’s standard payroll practices for executive officers, of $430,000 per
annum (“Base Salary”); (ii) an annual bonus (the “Annual Bonus”) of up to 65% of Base Salary, in accordance with the bonus plan then in effect for executive officers of the Company, as approved by the Signet Remuneration
Committee, which Annual Bonus shall be paid within 30 days following the preliminary announcement by Signet of its results for the related fiscal year, (iii) a long term incentive bonus of up to 35% of Base salary, payable in accordance with
the long term incentive plan for executive officers then in effect as approved by the Signet Remuneration Committee (the “Long Term Bonus”) and (iv) option awards, as determined in the sole discretion of the Signet Remuneration
Committee, in accordance with the option plan then in effect as approved by the Signet Remuneration Committee; provided, however, that notwithstanding that (x) this Agreement is dated as of the Execution Date, (y) the Term of
Employment hereunder commences on the Execution Date and (z) for the period from May 10, 1996 to the Execution Date the Executive was employed by the Company under the Original Agreement that was terminated by the Executive and the Company
as of the Execution Date, the Executive shall be paid his Base Salary effective as of May 1, 2004 and his

  

 4 

 Annual Bonus and Long Term Bonus effective as of February 2, 2004 (and in lieu of any other base salary
or annual bonus payable under the Original Agreement for the period from May 1, 2004 (or from February 1, 2004 in the case of the Annual Bonus and Long Term Bonus) to the Execution Date); and, provided further, that on or
prior to each May 1 of each year (beginning on May 1, 2005), the Board of Directors of the Company or the Signet Remuneration Committee shall review the amount of the Executive’s Base Salary then in effect and, in the absolute
discretion of the Board or such committee, the Base Salary may be increased, but not decreased, from such amount, based upon the performance of the Executive and other factors as may be considered by the Board or such committee to be relevant from
time to time; 
 (b) medical/dental, long term disability and life insurance benefits made available generally from time to time
by the Company to executive officers that are comparable with, but no less favorable to the Executive than, those benefits in effect as of the date of this Agreement with respect to the Executive; 
 (c) such deferred compensation benefits as may be made available generally from time to time by the Company to executive officers of the
Company upon the authorization and approval of the Signet Remuneration Committee; 
 (d) A lease by the Company of an automobile
having monthly lease payments not to exceed $800.00 per month in addition to: (i) the payment or reimbursement by the Company of all of the Executive’s costs for gas, repairs, maintenance and insurance premiums relating to such automobile;
(ii) an additional amount (the “Gross-Up Payment”) such that, after reduction for all federal, state and local income taxes, if any, payable by the Executive in respect of the reimbursement or

  

 5 

 
payment by the Company to the Executive of an expense described in this subsection (e) (a “Covered Expense”) and the Gross-Up Payment, the Executive shall retain an after-tax
amount equal to the amount of such Covered Expense; and (iii) an annual adjustment equal to the percentage change in the Consumer Price Index, All Urban Consumers, published by the Bureau of Labor Statistics of the U.S. Department of Labor
during the preceding twelve (12) months, or any successor index published by the U.S. Government (reasonably adjusted from time to time using suitable conversion factors in the event of any change in the base year used to calculate the index);
and 
 (e) such other perquisites and benefits as may be made available generally from time to time by the Company to executive
officers of the Company. 
 For purposes of subsection (d) of this Section 3, the federal, state and local income
taxes payable by the Executive in respect of a reimbursement or payment by the Company to the Executive of a Covered Expense or Gross-Up Payment shall be determined by taking into account all deductions allowable to the Executive for federal, state
or local income tax purposes in respect of the payment of a Covered Expense and any tax payable on a reimbursement or payment made under this subsection to the maximum extent thereof. 
 4. Termination. 
 (a) Disability. In the event of any physical or mental disability during the Term of Employment which renders the Executive incapable of performing the services required of him for any period or periods aggregating six months during
any twelve-month period, the Company shall have the right, upon written notice to the Executive, to terminate the Executive’s employment hereunder, effective upon the giving of such

  

 6 

 
notice (or such later date as shall be specified in such notice). Upon such termination, the Company shall have no further obligations hereunder, except to (i) pay the Executive his Base
Salary to the effective date of termination, (ii) pay the Executive for any Annual Bonus (which amount shall be paid within 30 days following the preliminary announcement by Signet of its results for the related fiscal year) and/or Long Term
Bonus (which amount shall be paid in accordance with the long term incentive plan for executive officers then in effect, as approved by the Signet Remuneration Committee) earned by Executive for a completed fiscal year (or, in the case of the Long
Term Bonus, a completed three-year fiscal period) prior to the effective date of such termination but which remain unpaid as of the date of termination, (iii) pay the Executive the pro-rata portion of the Annual Bonus for which he was then
eligible through the date of termination for the then current fiscal year (which amount shall be paid within 30 days following the preliminary announcement by Signet of its results for such fiscal year) and (iv) provide the Executive any other
benefits to which the Executive may otherwise have been entitled. For purposes of this Section 4(a), the Executive’s physical or mental disability shall be determined in accordance with any disability plan of applicable to the Company that
is then in effect. The Executive shall continue to have the obligations provided for in Sections 6 and 7 hereof. 
 (b)
Death. In the event of the death of the Executive during the Term of Employment, this Agreement shall automatically terminate and the Company shall have no further obligations hereunder, except to (i) pay the Executive’s estate the
Base Salary in effect at the time of the Executive’s death through the date of death and for six (6) months following such date, (ii) pay the Executive’s estate for any Annual Bonus (which

  

 7 

 
amount shall be paid within 30 days following the preliminary announcement by Signet of its results for the related fiscal year) and/or Long Term Bonus (which amount shall be paid in accordance
with the long term incentive plan for executive officers then in effect, as approved by the Signet Remuneration Committee) earned by Executive for a completed fiscal year (or, in the case of the Long Term Bonus, a completed three-year fiscal period)
prior to the date of death but which remain unpaid as of the date of death and (iii) pay the Executive’s estate the pro rata portion of the Annual Bonus for which he was then eligible through the date of death for the then current fiscal
year (which amount shall be paid within 30 days following the preliminary announcement by Signet of its results for such fiscal year). 
 (c) Cause. The Company shall have the right, upon written notice to the Executive, to terminate the Executive’s employment under this Agreement for Cause (as hereinafter defined), effective upon the giving of such notice (or
such later date as shall be specified in such notice), and the Company shall have no further obligations hereunder, except to pay the Executive his Base Salary prorated to the effective date of termination, and the Executive shall continue to have
the obligations provided in Sections 6 and 7 hereof. 
 For purposes of this Agreement, “Cause” means: 
 (i) fraud, embezzlement, gross insubordination on the part of the Executive or any act of moral turpitude or misconduct
(which misconduct adversely affects the business or reputation of the Company) by the Executive; 
 (ii)
conviction of or the entry of a plea of nolo contendere by the Executive for any felony; or 
  

 8 

 (iii) a material breach of, or the willful failure or refusal by the
Executive to perform and discharge, his duties, responsibilities or obligations under this Agreement. 
 5. Resignation upon
Termination. Upon the termination of the Executive’s employment hereunder for any reason, the Executive shall immediately be deemed to resign, and shall resign, from all offices and directorships held by him in the Company or any of its
subsidiaries or affiliates and shall execute any and all documents reasonably necessary to effect such resignations as requested by the Company. 
 6. Confidentiality; Ownership of Developments. (a) During the Term of Employment and for any time thereafter, the Executive shall keep secret and retain in strictest confidence and not
divulge, disclose, discuss, copy or otherwise use or suffer to be used in any manner, except in connection with the Business of the Company and of any of the subsidiaries or affiliates of the Company, any trade secrets, confidential or proprietary
information and documents or materials owned, developed or possessed by the Company or any of the subsidiaries or affiliates of the Company pertaining to the Business of the Company or any of the subsidiaries or affiliates of the Company;
provided, however, that such information referred to in this Section 6(a) shall not include information that is or has become generally known to the public or the jewelry trade without violation of this Section 6. 

(b) The Executive acknowledges that all developments, including, without limitation, inventions (patentable or otherwise), discoveries,
improvements, patents, trade secrets, designs, reports, computer software, flow charts and diagrams, data, documentation, writings and applications thereof relating to the Business or planned

  

 9 

 
business of the Company or any of the subsidiaries or affiliates of the Company that, alone or jointly with others, the Executive may create, make, develop or acquire during the Term of
Employment (collectively, the “Developments”) are works made for hire and shall remain the sole and exclusive property of the Company and the Executive hereby assigns to the Company all of his right, title and interest in and to all such
Developments. 
 (c) The provisions of this Section 6 shall, without any limitation as to time, survive the expiration or
termination of the Executive’s employment hereunder, irrespective of the reason for any termination. 
 7. Covenants Not
to Solicit and Not to Compete. The Executive agrees that during the Term of Employment and for a period of one year commencing upon the last date of Executive’s employment (the “Non-Competition Period”), the Executive shall not,
directly or indirectly, without the prior written consent of the Company; 
 (a) solicit, entice, persuade or induce any
employee, consultant, agent or independent contractor of the Company or of any of the subsidiaries or affiliates of the Company to terminate his or her employment or engagement with the Company or such subsidiary or affiliate, to become employed by
any person, firm or corporation other than the Company or such subsidiary or affiliate or approach any such employee, consultant, agent or independent contractor for any of the foregoing purposes; or 
 (b) directly or indirectly own, manage, control, invest or participate in any way in, consult with or render services to or for any person
or entity (other than for the Company or any of the subsidiaries or affiliates of the Company) which is engaged in the retail jewelry business; provided, however, that the restrictions of this Section 7(b) shall not extend to the
ownership, management or control of a retail jewelry business by

  

 10 

 
the Executive following the termination of his employment with the Company provided that such activity is no less than sixty (60) miles distant from any retail jewelry store of the Company
at the time of such termination of employment and provided, further, however, that the restrictions of this Section 7(b) shall not extend to the ownership of publicly traded securities in a company engaged in the retail
jewelry business, provided that such ownership does not exceed 1% of the outstanding voting securities of such company. 
 Notwithstanding
anything to the contrary contained herein, in the event Executive terminates his employment upon less than three hundred sixty (360) days notice to the Company as required by Section 1(c), the Non-Competition Period shall be extended by an
amount of time equal to three hundred sixty (360) days less the amount of notice actually given by the Executive to the Company; provided, however, if such termination by Executive upon less than three hundred sixty
(360) days notice is within sixty (60) days following a Change in Control (as defined below), Executive’s obligations pursuant to clause (b) above shall continue for the Non-Competition Period without giving effect to the
extension of time provided for herein. For purposes of this Agreement, a “Change in Control” shall mean: (i) the consummation of a merger or consolidation of the Company with or into another entity or any other corporate
reorganization (other than the Signet Group plc (“Signet”) or an affiliate of Signet or the Company), if persons who were not shareholders of the Company immediately prior to such merger, consolidation or other reorganization own
immediately after such merger, consolidation or other reorganization more than fifty percent (50% ) of the voting power of the outstanding securities of each of (A) the continuing or surviving entity and (B) any direct or indirect

  

 11 

 
parent corporation of such continuing or surviving entity or (ii) any person or group of related persons (other than Signet or an affiliate of Signet or the Company) shall acquire beneficial
ownership of more than fifty percent (50%) of the voting power of all classes of stock of the Company. A transaction shall not constitute a “Change in Control” if its sole purpose is to change the state of the Company’s incorporation
or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction. 
 8. Specific Performance. The Executive acknowledges that the services to be rendered by the Executive are of a special, unique and
extraordinary character and, in connection with such services, the Executive will have access to confidential information vital to the Company’s Business and the subsidiaries and affiliates of the Company. By reason of this, the Executive
consents and agrees that if the Executive violates any of the provisions of Sections 6 or 7 hereof, the Company and the subsidiaries and affiliates of the Company would sustain irreparable injury and that monetary damages will not provide adequate
remedy to the Company and that the Company shall be entitled to have Sections 6 or 7 specifically enforced by any court having equity jurisdiction. Nothing contained herein shall be construed as prohibiting the Company or any of the subsidiaries or
affiliates of the Company from pursuing any other remedies available to it for such breach or threatened breach, including the recovery of damages from the Executive. 
 9. Entire Agreement. This Agreement embodies the entire agreement of the parties with respect to the Executive’s employment and supersedes any other prior oral or written agreements,
arrangements or understandings between the Executive and 
  

 12 

 
the Company. This Agreement may not be changed or terminated orally but only by an agreement in writing signed by the parties herein. 
 10. Governing Law: Jurisdiction. (a) This Agreement shall be subject to, and governed by, the laws of the State of Ohio applicable to
contracts made and to be performed therein. 
 (b) Any action to enforce any of the provisions of this Agreement shall be
brought in a court of the State of Ohio located in Summit County or in a Federal court located in Cleveland, Ohio. The parties consent to the jurisdiction of such courts and to the service of process in any manner provided by Ohio law. Each party
irrevocably waives any objection which it may now or hereafter have to the venue of any such suit, action or proceeding brought in such court. 
 (c) The prevailing party in any action to enforce any of the provisions of this Agreement shall be entitled to reimbursement from the other party for its or his costs and expenses (including attorneys
fees and expenses) incurred in connection with such action. 
 11. Assignability. The obligations of the Executive may
not be delegated and the Executive may not, without the Company’s written consent thereto, assign, transfer, convey, pledge, encumber, hypothecate or otherwise dispose of this Agreement or any interest herein. Any such attempted delegation or
disposition shall be null and void and without effect. This Company and the Executive agree that this Agreement and all of the Company’s rights and obligations hereunder may be assigned or transferred by the Company to any successor to the
Company. 
  

 13 

 12. Severability. If any provision of this Agreement or any part thereof, including,
without limitation, Sections 6 and 7, as applied to either party or to any circumstances shall be adjudged by a court of competent jurisdiction to be void or unenforceable, the same shall in no way affect any other provision of this Agreement or
remaining part thereof, which shall be given full effect without regard to the invalid or unenforceable part thereof, or the validity or enforceability of this Agreement. 
 If any court construes any of the provisions of Section 6 or 7, or any part thereof, to be unreasonable because of the duration of such provision or the geographic scope thereof, such court may reduce the
duration or restrict or redefine the geographic scope of such provision and enforce such provision as so reduced, restricted or redefined. 
 13. Notices. All notices to the Company or the Executive permitted or required hereunder shall be in writing and shall be delivered personally, by telecopier or by courier service providing for
next-day delivery or sent by registered or certified mail, return receipt requested, to the following addresses: 
 The Company:

 Sterling Jewelers Inc. 
 375 Ghent Road 
 Akron, Ohio 44313 
 Fax: (330) 668-5191 
 Attn: Chief Financial Officer 
 with a copy to: 
 Weil, Gotshal & Manges LLP 
 767 Fifth Avenue 
 New York, NY 10153 
 Fax: (212) 310-8007 
 Attn: Michael Kam 
 The Executive: 
 William Montalto 
 Sterling Jewelers Inc. 
 375 Ghent Road 
 Akron, Ohio 44313 
  

 14 

 Either party may change the address to which notices shall be sent by sending written notice
of such change of address to the other party. Any such notice shall be deemed given, if delivered personally, upon receipt; if telecopied, when telecopied, if sent by courier service providing for next-day delivery, the next business day following
deposit with such courier service, and if sent by certified or registered mail, three days after deposit (postage prepaid) with the U. S. mail service. 
 14. Paragraph Headings. The paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

 15. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an
original, but all of which taken together shall constitute one and the same instrument. 
  

 15 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date
first written above. 
  

			
	STERLING INC.
		
	By:	 	/s/ Terry Burman
	Name:	 	Terry Burman
	Title:	 	Chairman
		 	
	/s/ William Montalto
	WILLIAM MONTALTO

  

 16Form of Letter of Appointment of Independent Directors

 Exhibit 10.31 
 STRICTLY PRIVATE & CONFIDENTIAL 
 ADDRESSEE ONLY 
 9 December 2008 
 NAME 
 ADDRESS 
 Dear
                            , 
 I write to confirm your appointment as an independent director of Signet Jewelers Limited (the “Company”), with effect from 27 October 2008. I set out below the terms of your
appointment. 
  

	1.	Definitions 

 In this
letter: 
  

	1.1	“Board” means the board of directors of the Company from time to time; 

  

	1.2	“Combined Code” means the principles of good governance and code of best practice published and maintained by the Financial Reporting Council of the
United Kingdom; 

  

	1.3	“Bye-laws” means the bye-laws of the Company from time to time; 

  

	1.4	“Companies Act” means the Companies Act 1981 of Bermuda, as amended; 

  

	1.5	“Group” means the Company and any subsidiary or subsidiary undertaking of the Company from time to time; 

  

	1.6	“LPDT Rules” means the Listing, Prospectus, Disclosure and Transparency Rules made by the UK Listing Authority; 

  

	1.7	“NYSE” means the New York Stock Exchange; and 

  

	1.8	“SEC” means the US Securities and Exchange Commission. 

  

	2.	Term of Appointment 

  

	2.1	Your appointment is subject to the provisions of the Bye-laws regarding appointment, fees, expenses, retirement, (including the rotation system whereby one-third of the
Board shall retire from office at every Annual General Meeting), disqualification and removal of directors and will terminate forthwith without any entitlement to compensation (save for any arrears of compensation which may be due under the terms of
this letter) if: 

  

	 	2.1.1	you are not re-elected at an Annual General Meeting of the Company at which you retire and offer yourself for re-election in accordance with the Bye-laws; or

  

	 	2.1.2	you are required to vacate office for any reason pursuant to any of the provisions of the Bye-laws; or 

  

	 	2.1.3	you are removed as a director or otherwise required to vacate office under any applicable law. 

	2.2	Subject to clause 2.1, to satisfactory performance by you, and to the results of the annual review as set out in clause 9, it is anticipated that your initial
appointment as an independent director will be until the Annual General Meeting in 2009 and then for a term of three years, unless otherwise terminated earlier by you at your discretion or by the Board at its discretion upon one month’s written
notice. Independent directors are normally expected to serve terms of appointment of 3 years. However, the Board may, subject to the Bye-laws, agree with you in writing that you will serve as a director until a later date. 

 

	3.	Duties 

  

	3.1	You will be expected to devote such time as is necessary for the proper performance of your duties, which is likely to be at least 20 days per year. You will have all
the usual duties of an independent director under Bermuda law and applicable listing standards of the NYSE, including attendance at board meetings, executive sessions, the annual general meeting, meetings of independent directors, meetings with
investors and shareholders and other Board events such as site visits, together with such additional duties as may be agreed with the Board, and which may relate to the business of the Company or any other member of the Group. You will be required
to serve on such committees as the Board may request, including but not limited to Audit, and/or Compensation and/or Nomination and Corporate Governance Committees. In addition, you will be expected to devote appropriate preparation and travel time
ahead of each meeting. In carrying out your duties, you shall have regard to the Bye-laws, Bermuda law, applicable SEC rules and NYSE listing standards, and such principles of the Combined Code as the Board considers appropriate for the Company from
time to time. 

  

	3.2	By accepting this appointment you undertake that, taking into account all other commitments you may have, you are able to devote sufficient time to properly discharge
your duties as an independent director of the Company and member of the Audit, and/or Compensation, and/or Nomination and Corporate Governance Committees. 

  

	3.3	If you are required to spend substantially longer than the likely time commitment set out in clause 3.1 on your duties, the Company may at its sole and absolute
discretion make one or more specific payments to you (subject to any limits on directors’ fees contained in the Bye-laws) in addition to the fees set out in clause 7 of this letter, which will be subject to any deductions which the Company may
be required to make (including in respect of tax and other contributions (including national insurance contributions)). 

  

	3.4	You will be expected to faithfully, efficiently, competently and diligently perform your duties and exercise your powers in good faith and in the best interests of the
Company in your role as an independent director having regard in particular to the Companies Act, the SEC rules and NYSE listing standards and such principles of the Combined Code that the Board deems appropriate from time to time.

	3.5	During the continuance of your appointment you shall: 

  

	 	3.5.1	to the best of your ability, attend all meetings of the Board and of committees of the Board of which you are a member, and annual general meetings of the Company;

  

	 	3.5.2	use your reasonable endeavours to promote and extend the interests and reputation of the Group, including assisting the Chairman and the Board in relation to public and
corporate affairs and promotion of the success of the Company in general through application of your particular knowledge, skill and experience; 

  

	 	3.5.3	accurately complete questionnaires as and when requested by the Company, and promptly notify the Company of any subsequent changes which may have occurred in relation
to the responses provided in such questionnaires (in particular, where such changes may impact your independence as determined by the Board under NYSE listing rules); 

  

	 	3.5.4	promptly declare, so far as you are aware, the nature of any interest, whether direct or indirect, in any contract or proposed contract entered into by any member of
the Group; 

  

	 	3.5.5	acquire and then maintain a minimum holding of common shares of the Company equal to a total stock value of US $150,000 whilst in office as a director of the Company,
such holding to be reached within five years of appointment. Once the minimum stock holding requirement has been achieved at any given stock price, the requirement would be considered to have been met notwithstanding a subsequent change in stock
price resulting in a reduction in the value of the stock held; 

  

	 	3.5.6	comply where relevant with any applicable law, rules, regulations and stock exchange listing standards, and policies and codes of the Company, including the
Company’s Code of Conduct applicable to directors, officers and employees; 

  

	 	3.5.7	comply where relevant with any rule of law or regulation of any competent authority or of the Company, from time to time in force in relation to dealing in shares,
debentures and other securities of the Company and unpublished price sensitive information affecting the shares, debentures or other securities of the Company; 

  

	 	3.5.8	observe the LPDT, SEC rules and the NYSE listing standards, as applicable; 

  

	 	3.5.9	comply with all reasonable requests, instructions and regulations made or given by the Board (or by any duly authorised committee thereof) and give to the Board such
explanations, information and assistance as the Board may reasonably require; and 

  

	 	3.5.10	in the event that you have concerns which cannot be resolved (i) about the way in which the Company is being run or (ii) about a course of action being
proposed by the Board, discuss these concerns with another member of the Board, or raise these concerns at a meeting of the Board. 

	4.	Provision of Information 

  

	4.1	Following your appointment, the Board will provide an induction programme. This will include the provision of certain information. The Company will also arrange
meetings with senior and middle management and site visits as well as meetings with major shareholders in the Company within 12 months of your appointment. 

  

	4.2	In the event that you require further information or advice in relation to the Company, including in relation to compliance with applicable rules and regulations,
during the course of your appointment, you should contact the Group Company Secretary. 

  

	4.3	During the course of your appointment, you will be expected, if necessary, to update your skills and knowledge for the purposes of fulfilling your role as an
independent director of the Company and as a chairman or member of any committee of the Board to which you may be appointed. The Company will explore, make available and design and provide continuing education opportunities for directors, from time
to time. You should contact the Group Company Secretary if you have any queries in relation to professional development. 

  

	5.	Confidential Information 

  

	5.1	You agree that both during and after your time as a director of the Company, you will not use for your own or another’s benefit or disclose or permit the
disclosure of any confidential information about the Company, its suppliers, customers or other constituents or any member of the Group, other than as appropriate in connection with the proper performance of your duties as a director or otherwise in
accordance with prior authorization provided by the Company. Confidential information shall include, without limitation, all and any information, whether or not recorded, of the Company or of any members of the Group which you have obtained by
virtue of your appointment and which (i) the Company or any member of the Group regards as confidential, (ii) is apparently confidential by reason of its nature or the circumstances in which it comes to your knowledge, and/or (iii) in
respect of which the Company or any member of the Group is bound by any obligation of confidence to a third party. Confidential information may include, without limitation: 

  

	 	5.1.1	all and any information relating to results of operations, financial condition, plans and prospects, business methods, corporate plans, future business strategy,
management systems, borrowing activities, possible transactions with other parties, possible restructuring, liquidity issues, litigation (pending or threatened), senior management changes, securities offerings, dividend policy, and maturing new
business opportunities; 

  

	 	5.1.2	all and any information relating to research and/or development projects; 

	 	5.1.3	all and any information concerning the curriculum vitae, compensation details, work-related experience and other personal information concerning those employed or
engaged by the Company or by any member of the Group; 

  

	 	5.1.4	all and any information relating to marketing or sales of any past, present or future product or service of the Company or any member of the Group including sales
targets and statistics, market share and pricing statistics, marketing surveys and strategies, marketing research reports, sales techniques, price lists, mark-ups, discounts, rebates, tenders, advertising and promotional material, credit and payment
policies and procedures, and lists and details of customers, prospective customers, suppliers, prospective suppliers, joint venture partners and prospective joint venture partners, including their identities, business requirements and contractual
negotiations and arrangements with the Company or any member of the Group; 

  

	 	5.1.5	all and any trade secrets, secret formulae, processes, inventions, design, know-how, research projects, technical specifications and other technical information in
relation to the creation, production or supply of any past, present or future product or service of the Company or any member of the Group, including all and any information relating to the working of any product, process, invention, improvement or
development carried on or used by the Company or any member of the Group and information concerning the intellectual property portfolio and strategy of the Company or of any member of the Group; and 

  

	 	5.1.6	any other information that a reasonable investor would consider important in making a decision to buy, hold or sell the Company’s securities.

  

	5.2	The restrictions contained in this clause 5 shall cease to apply to any confidential information which: 

  

	 	5.2.1	may (other than by reason of your breach of these terms) become available to the public generally; or 

  

	 	5.2.2	you are required to disclose by law, governmental rule or regulation (in which event you shall promptly notify the Company a reasonable period in advance of such
disclosure). 

  

	5.3	You also agree during your appointment that you will not, other than for the benefit of the Company, make any notes (which shall include any notes you make on Board, or
Board committee, minutes or papers, or at or for the purpose of Board meetings, in each case, for the benefit of the Company), memoranda, electronic records, tape records, films, photographs, plans, drawings or any form of record relating to any
matter within the scope of the business or concerning the dealings or affairs of the Group and will return any such items at any time at the request of the Board. 

  

	6.	Other Directorships, Appointments and Interests 

  

	6.1	 You confirm that you have notified the Board in writing of all your other directorships, appointments (including employment relationships) and
interests, including any directorship, appointment or interest in a company,

	 	 
business or undertaking which competes or is likely to compete with the Company or any other member of the Group or which is a customer or supplier of any such company or which could otherwise
potentially give rise to a conflict with your duties with the Company (a “competing interest”). 

  

	6.2	You undertake that during the term of your appointment you will: 

  

	 	6.2.1	disclose any proposed new directorship or appointment to the Chairman before accepting it and following acceptance, promptly disclose it to the Board;

  

	 	6.2.2	promptly notify in writing, in the first instance to the Chairman and subsequently to the Board, any subsequent changes to any such directorship or appointment or
competing interest; and 

  

	 	6.2.3	not acquire any new competing interest (except as the holder for investment of less than 3 per cent. of any class of securities listed on a recognised stock
exchange) without the prior consent of the Board in writing. If you anticipate any possible conflict might arise you should discuss the matter with the Chairman in advance. 

  

	7	Fees 

  

	7.1	You will be entitled to an annual fee at the rate of US$180,000 per annum which total shall be split so as US $90,000 is paid in cash, and US $90,000 is paid in
restricted stock to be delivered annually at the time of the annual general meeting. The fee will be paid less any deductions which the Company may be required to make including in respect of tax and other contributions (including national insurance
contributions). 

  

	7.2	The fee in clause 7.1 will be paid by the Company in respect of your services as a director of the Company, and does not include additional remuneration paid to you in
respect of other duties which you may perform for the Company (including, but not limited to, special remuneration pursuant to Bye-law 46 of the Bye-laws). 

  

	7.3	All fees will be payable in arrears by equal quarterly instalments in US dollars. You will not be eligible for the grant of options or other incentives under any of the
Company’s share option schemes as part of your remuneration other than as set out herein. 

  

	7.4	Whilst a restricted stock plan is not currently in place it is the Company’s current intention that such a plan be introduced and shareholder approval sought at
the annual general meeting to be held in 2009. The specific details of the plan are yet to be established. However the restricted stock award relating to the remainder of the year 2008/09 will be delivered, subject to shareholder approval of a
restricted stock plan, at the time of the next annual general meeting to be held in 2009. In the event a restricted stock plan is not established, at the annual general meeting to be held in 2009 the entire annual fee of US $180,000 will be paid in
cash until the restricted stock plan is implemented. 

	8	Expenses, Indemnity and Insurance 

  

	8.1	The Company shall reimburse to you all expenses reasonably incurred by you in the proper performance of your obligations under this letter provided that you supply
receipts or other evidence of expenditure. 

  

	8.2	Subject to the Bye-laws, your expenses may include professional fees if it is necessary in the furtherance of your duties for you to seek independent professional
advice, subject to you having first consulted the Chairman or the Group Company Secretary as appropriate. Any such payment by the Company would, of course, be subject to (i) any applicable restriction under applicable company law and the
Bye-laws, and (ii) the terms of the Deed of Indemnity provided by the Company dated 12 November 2008 (the “Deed of Indemnity”). 

  

	8.3	The Company currently has directors’ and officers’ liability insurance for which the current indemnity limit is £100 million plus
£50 million “Side A Difference in Conditions” cover. A summary of the current policy document has been provided to you. The Company will provide and maintain directors’ and officers’ liability insurance coverage for
you in respect of the period for which you are a director of the Company at such levels, for such risks and subject to such terms, and for such a period after you cease to be a director of the Company, as the Company provides and maintains such
cover for its directors generally for each year thereafter, including such self insurance coverage as the Company makes available or obtains on behalf of itself or its directors. 

  

	9	Review 

 The performance
of individual directors, and of the Board as a whole, will be evaluated annually. If, in the interim, there are any matters which cause you concern in relation to your role, you should raise them with the Chairman as soon as possible. 
  

	10	Termination of Appointment 

 On the termination of your appointment: 
  

	10.1	you will at the request of the Company (where relevant) resign (in writing) from the office of director and you irrevocably authorise the Company as your attorney in
your name and on your behalf to sign all documents and do all things necessary to give effect to this; 

  

	10.2	you will surrender to an authorised representative of the Company all correspondence, documents (including without limitation Board minutes and Board papers (save for
Board minutes and Board papers upon which you have made notes provided that they remain subject to the confidentiality obligations set out in clause 5 of this letter)), and copies thereof or other property of the Group made or received by you in the
course of your directorship (whether before or after the date of this letter) provided that you shall be permitted access to such relevant documentation previously under your control and which you returned pursuant to this clause for the limited
purpose of defending any legal proceedings to which you are a party or through which you are seeking relief by a court; and 

	10.3	without prejudice to any right which you may have to recover any fee owing to you pursuant to clause 7 of this letter, you hereby agree that you shall not be entitled
to and shall not pursue any action or claim for compensation from the Company whether such termination occurs before or after the date of expiry of the period set out in clause 2.2. 

  

	11	Miscellaneous 

  

	11.1	Nothing in this letter shall create the relationship of employee and employer between you and the Company. 

  

	11.2	The agreement constituted by this appointment letter shall be governed by, and construed in accordance with, Bermuda law. 

  

	11.3	Both you and the Company irrevocably agree that the Courts of Bermuda shall have exclusive jurisdiction in relation to any claim, dispute or difference concerning this
appointment letter and any matter arising therefrom. 

  

	11.4	Both you and the Company irrevocably waive any right that you or the Company may have to object to an action being brought in those Courts, to claim that the action has
been brought in an inconvenient forum, or to claim that those Courts do not have jurisdiction. 

  

	12	Entire Agreement and Severability 

  

	12.1	This appointment letter together with the Deed of Indemnity represents the entire understanding, and constitutes the whole agreement, in relation to your appointment
and supersedes any previous agreement between yourself and the Company with respect thereto and, without prejudice to the generality of the foregoing, excludes any warranty, condition or other undertaking implied at law or by custom.

  

	12.2	You confirm that: 

  

	 	12.2.1	in entering into the agreement constituted by this appointment letter you have not relied on any representation, warranty, assurance, covenant, indemnity, undertaking
or commitment which is not contained in this appointment letter; and 

  

	 	12.2.2	in any event, without prejudice to any liability for fraudulent misrepresentation or fraudulent misstatement, the only rights or remedies in relation to any
representation, warranty, assurance, covenant, indemnity, undertaking or commitment given or action taken in connection with this appointment are under this appointment letter and, for the avoidance of doubt and without limitation, neither party has
any right or remedy (whether by way of a claim for contribution or otherwise) in tort (including negligence) or for misrepresentation (whether negligent or otherwise, and whether made prior to, and/or in, this appointment letter).

  

	12.3	In the event that any part (including any sub-clause or part thereof) of this appointment letter shall be void or unenforceable by reason of any applicable law, it
shall be deleted and the remaining parts of this appointment letter shall continue in full force and effect and, if necessary, both parties shall use their best endeavours to agree any amendments to the appointment letter necessary to give effect to
the spirit of this appointment letter. 

	13	Counterparts 

 This
appointment letter may be executed by facsimile and in counterparts, all of which taken together shall constitute one and the same instrument. 
  

	14	Waiver 

 The failure of
either party to insist upon strict performance of any of the terms in this appointment letter shall not constitute a waiver of any of its rights hereunder. Further, the waiver by either party of the breach of any provision of this appointment letter
shall not operate or be construed as a waiver of any subsequent breach thereof. 
  

	15	Assignment 

 The rights
and benefits of the Company under this appointment letter shall be transferable and shall inure to the benefit of its successors and assigns. Your duties and obligations under this appointment letter are personal and therefore you may not assign any
right or duty under this appointment letter without the prior written consent of the Company. 
  

	16	Notices 

 Any notice to be
given under the terms of this letter shall, in the case of notice to the Company, be deemed to be given if left at or sent by first class post or facsimile transmission to the registered office for the time being of the Company marked for the
attention of the Group Company Secretary and, in the case of notice to you, if handed to you personally or left at or sent by first class post or facsimile transmission to your last-known address. Any such notice shall be deemed to be given at the
time of its delivery or despatch by facsimile transmission or on the next following weekday (not being a public holiday) after it was posted. 
 Kindly confirm your agreement to the terms set out above by signing the endorsement on the enclosed copy of this letter in the presence of an independent adult witness who should also sign and add his or her full name, address and
occupation. Please return the copy to me at the above address. In returning this letter duly signed, you agree that the Company may make this letter publicly available. 
 Yours sincerely 
 Sir Malcolm Williamson 
 Chairman 
 for and on behalf of Signet
Jewelers Limited 

					
	EXECUTED as a DEED
	by	 	
			
	Signed:	 	  
	 	

  

					
	Date:	 	  
	 	

  

			
	in the presence of
		
	 	  	Witness Name
		
	 	  	Witness Signature
		
	 	  	Full Name
		
	 	  	Address
		
	 	  	
		
	 	  	
		
	 	  	Occupation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]